Tegaderm ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
86Pulmonary arterial hypertension1

86. Pulmonary arterial hypertension


Clinical trials : 1,181 Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01393795
(ClinicalTrials.gov)
August 201122/6/2011Qutenza®-Remodulin® in Pulmonary Arterial Hypertension PatientsA Double-blind, Randomized, Crossover Clinical Study to Assess the Efficacy of Qutenza® for the Reduction of Site Pain Caused by Continuous Subcutaneous Infusion of Remodulin®, in Pulmonary Arterial Hypertension PatientsPulmonary Hypertension;PainDrug: Qutenza;Drug: TegadermImperial College LondonUnited TherapeuticsCompleted18 YearsN/ABoth11Phase 2United Kingdom